Evidence map›Paper›PMID 36597354›Full record

ArticleAIDS research and human retroviruses2023

Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.

Pablo F Belaunzarán-Zamudio, Lizbeth Naranjo, Yanink Caro-Vega, José R Castillo-Mancilla, Antonio Camiro-Zuñiga, Ruth Fuentes-García, Brenda E Crabtree-Ramírez, Juan G Sierra-Madero

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [ART adherence and its association with depression, anxiety and stress].Revista medica del Instituto Mexicano del Seguro Social · 2025
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Pablo F Belaunzarán-ZamudioDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0003-4775-4734
Lizbeth NaranjoFacultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Yanink Caro-VegaDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico.
José R Castillo-MancillaDivision of Infectious Diseases, University of Colorado-Anschutz Medical Campus, USA.
Antonio Camiro-ZuñigaDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0003-0957-9509
Ruth Fuentes-GarcíaFacultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Brenda E Crabtree-RamírezDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico.
Juan G Sierra-MaderoDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversidad Nacional Autónoma de México · MXUniversity of Colorado Anschutz Medical Campus · US

Funding

New Pharmacologic Measures of ART Adherence and Exposure: Pathway to Clinical ImplementationR01AI145453 · NIAID · UNIVERSITY OF COLORADO DENVER · PI ANDERSON, PETER L. · 2019 to 2023
$3.7M
NIAID NIH HHS R01 AI145453
6 · The paper itself

Abstract

Suboptimal adherence to antiretroviral therapy (ART) in people with HIV, even during sustained viral suppression, is associated with persistent inflammation, immune activation, and coagulopathy. Persistently low CD4-CD8 Ratio has been also associated with residual inflammation, is a good predictor of increased risk of death and more widely available than inflammatory biomarkers. We tested the hypothesis that the CD4-CD8 Ratio is associated with ART adherence during periods of complete viral suppression. We used the Medication Possession Ratio based in pharmacy registries as measure of adherence and time-varying, routine care CD4 and CD8 measurements as outcome. We used a linear mixed model for longitudinal data, including fixed effects for sex, age, education, date of ART initiation, AIDS-related conditions, and baseline CD4 to model the outcome. In 988 adults with a median follow-up of 4.13 years, higher ART adherence was independently associated with a modest increase in CD4-CD8. For each increasing percentage point in adherence, the CD4-CD8 Ratio increased 0.000857 (95% confidence interval [CI] -0.000494 to 0.002209,

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsAdultAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveCD4-CD8 RatioCD4 Lymphocyte CountHumansInflammationMedication AdherenceMexicoViral LoadAnti-HIV AgentsAnti-Retroviral Agentsacquired immunodeficiency syndromeadultcohort studieslinear mixed modelspharmacysustained virologic response

Identifiers

PMID36597354
PMCPMC9986006
OpenAlexW4313488334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.